Physical activity levels in locally advanced rectal cancer patients following neoadjuvant chemoradiotherapy and an exercise training programme before surgery: a pilot study

Lisa Loughney, Malcolm A West, Borislav D Dimitrov, Graham J Kemp, Michael Pw Grocott, Sandy Jack, Lisa Loughney, Malcolm A West, Borislav D Dimitrov, Graham J Kemp, Michael Pw Grocott, Sandy Jack

Abstract

Background: The aim of this pilot study was to measure changes in physical activity level (PAL) variables, as well as sleep duration and efficiency in people with locally advanced rectal cancer (1) before and after neoadjuvant chemoradiotherapy (CRT) and (2) after participating in a pre-operative 6-week in-hospital exercise training programme, following neoadjuvant CRT prior to major surgery, compared to a usual care control group.

Methods: We prospectively studied 39 consecutive participants (27 males). All participants completed standardised neoadjuvant CRT: 23 undertook a 6-week in-hospital exercise training programme following neoadjuvant CRT. These were compared to 16 contemporaneous non-randomised participants (usual care control group). All participants underwent a continuous 72-h period of PA monitoring by SenseWear biaxial accelerometer at baseline, immediately following neoadjuvant CRT (week 0), and at week 6 (following the exercise training programme).

Results: Of 39 recruited participants, 23 out of 23 (exercise) and 10 out of 16 (usual care control) completed the study. In all participants (n = 33), there was a significant reduction from baseline (pre-CRT) to week 0 (post-CRT) in daily step count: median (IQR) 4966 (4435) vs. 3044 (3265); p < 0.0001, active energy expenditure (EE) (kcal): 264 (471) vs. 154 (164); p = 0.003, and metabolic equivalent (MET) (1.3 (0.6) vs. 1.2 (0.3); p = 0.010). There was a significant improvement in sleep efficiency (%) between week 0 and week 6 in the exercise group compared to the usual care control group (80 (13) vs. 78 (15) compared to (69 ((24) vs. 76 (20); p = 0.022), as well as in sleep duration and lying down time (p < 0.05) while those in active EE (kcal) (152 (154) vs. 434 (658) compared to (244 (198) vs. 392 (701) or in MET (1.3 (0.4) vs. 1.5 (0.5) compared to (1.1 (0.2) vs. 1.5 (0.5) were also of importance but did not reach statistical significance (p > 0.05). An apparent improvement in daily step count and overall PAL in the exercise group was not statistically significant.

Conclusions: PAL variables, daily step count, EE and MET significantly reduced following neoadjuvant CRT in all participants. A 6-week pre-operative in-hospital exercise training programme improved sleep efficiency, sleep duration and lying down time when compared to participants receiving usual care.

Trial registration: Clinicaltrials.gov NCT01325909.

Keywords: Exercise; Neoadjuvant cancer treatment; Physical activity; Prehabilitation; Rectal cancer; Surgery.

Figures

Fig. 1
Fig. 1
The patient pathway and the time points of assessments

References

    1. Adamsen L, Quist M, Andersen C, Moller T, Herrstedt J, Kronborg D, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339:3410. doi: 10.1136/bmj.b3410.
    1. Black AE, Coward WA, Cole TJ, Prentice AM. Human energy expenditure in affluent societies: an analysis of 574 doubly-labelled water measurements. Eur J Clin Nutr. 1996;50:72–92.
    1. Booth FW, Gordon SE, Carlson CJ, Hamilton MT. Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol. 2000;88(2):774–87.
    1. Campbell A, Mutrie N, White F, McGuire F, Kearney N. A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment. Eur J Oncol Nurs. 2005;9(1):56–63. doi: 10.1016/j.ejon.2004.03.007.
    1. Cereda E, Turrini M, Ciapanna D, Marbello L, Pietrobelli A, Corradi E. Assessing energy expenditure in cancer patients: a pilot validation of a new wearable device. JPEN J Parenter Enteral Nutr. 2007;31(6):502–7. doi: 10.1177/0148607107031006502.
    1. Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer. 2013;119(24):4333–40. doi: 10.1002/cncr.28376.
    1. Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and Quality of Life in Breast Cancer Patients. J Pain Symptom Manage. 2002;24:5. doi: 10.1016/S0885-3924(02)00500-6.
    1. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–8. doi: 10.1136/thx.2006.060145.
    1. Hiremath SV, Ding D, Farringdon J, Vyas N, Cooper RA. Physical activity classification utilizing SenseWear activity monitor in manual wheelchair users with spinal cord injury. Spinal Cord. 2013;51(9):705–9. doi: 10.1038/sc.2013.39.
    1. Hoffman AJ, Brintnall RA, von Eye A, Jones LW, Alderink G, Patzelt LH, et al. Home-based exercise: promising rehabilitation for symptom relief, improved functional status and quality of life for post-surgical lung cancer patients. J Thorac Dis. 2014;6(6):632–40.
    1. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical Activity and Survival After Breast Cancer Diagnosis. JAMA. 2005;11(5):106.
    1. Jack S, West MA, Raw D, Marwood S, Ambler G, Cope TM, et al. The effect of neoadjuvant chemotherapy on physical fitness and survival in patients undergoing oesophagogastric cancer surgery. Eur J Surg Oncol. 2014;40(10):1313–20. doi: 10.1016/j.ejso.2014.03.010.
    1. Jones LW, Alfano CM. Exercise-oncology research: past, present, and future. Acta Oncol. 2013;52(2):195–215. doi: 10.3109/0284186X.2012.742564.
    1. Matthews CE, Hagstromer M, Pober DM, Bowles HR. Best practices for using physical activity monitors in population-based research. Med Sci Sports Exerc. 2012;44(1):68–76. doi: 10.1249/MSS.0b013e3182399e5b.
    1. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24(22):3527–34. doi: 10.1200/JCO.2006.06.0855.
    1. Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B, et al. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology. 2005;14(6):464–77. doi: 10.1002/pon.863.
    1. Moros MT, Ruidiaz M, Caballero A, Serrano E, Martinez V, Tres A. Effects of an exercise training program on the quality of life of women with breast cancer on chemotherapy. Rev Med Chil. 2010;138(6):715–22. doi: 10.4067/S0034-98872010000600008.
    1. Naraphong W, Lane A, Schafer J, Whitmer K, Wilson BR. Exercise intervention for fatigue-related symptoms in Thai women with breast cancer: A pilot study. Nurs Health Sci. 2015;17(1):33–41. doi: 10.1111/nhs.12124.
    1. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. J Clin Oncol. 1982;5(6):649–55. doi: 10.1097/00000421-198212000-00014.
    1. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Phys Med Rehab. 2005;86(10):1979–85. doi: 10.1016/j.apmr.2005.04.016.
    1. Pucciarelli S, Gagliardi G, Maretto I, Lonardi S, Friso ML, Uros E, et al. Long-Term Oncologic Results and Complications After Preoperative Chemoradiotherpay for Rectal Cancer: A Single-Institution Experience After a Median Follow-Up of 95 Months. Ann Surg Oncol. 2009;16:893–899. doi: 10.1245/s10434-009-0335-6.
    1. Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S, et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J. 2013;42(5):1205–15. doi: 10.1183/09031936.00134312.
    1. Shepard RJ. Limits to the measurement of habitual physical activity by questionnaires. BRJ Sports Med. 2003;37(3):197–206. doi: 10.1136/bjsm.37.3.197.
    1. St-Onge M, Mignault D, Allison D, Rabasa-Lhoret R. Evaluation of a portable device to measure daily energy expenditure in free-living adults. Am J Clin Nutr. 2007;85(3):742–9.
    1. Thomas RJ, Holm M, Al-Adhami A. Physical activity after cancer: An evidence review of the international literature. Br J Med Pract. 2014;7(1):708.
    1. Tudor-Locke C, Washington TL, Hart TL. Expected values for steps/day in special populations. Prev Med. 2009;49(1):3–11. doi: 10.1016/j.ypmed.2009.04.012.
    1. Vassbakk-Brovold K, Kersten C, Fegran L, Mjåland O, Mjåland S, Seiler S, et al. Cancer patients participating in a lifestyle intervention during chemotherapy greatly over-report their physical activity level: a validation study. BMC Sports Sci Med Rehabil. 2016;8:10. doi: 10.1186/s13102-016-0035-z.
    1. Wasserberg N. Interval to surgery after neoadjuvant treatment for colorectal cancer. World J Gastroenterol. 2014;20(15):4256–62. doi: 10.3748/wjg.v20.i15.4256.
    1. West MA, Loughney L, Barben CP, Sripadam R, Kemp GJ, Grocott MP, et al. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients. Eur J Surg Oncol. 2014;40(11):1421–8. doi: 10.1016/j.ejso.2014.03.021.
    1. West MA, Loughney L, Lythgoe D, Barben CP, Sripadam R, Kemp GK, et al. Effect of prehabilitation on objectively measured physical fitness after neoadjuvant treatment in preoperative rectal cancer patients: a blinded interventional pilot study. Br J Anaesth. 2015;114(2):244–51. doi: 10.1093/bja/aeu318.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi